| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | SGEN | Common Stock | Options Exercise | $2.61K | +100 | +0.01% | $26.10 | 668K | Mar 7, 2022 | Direct | F1 |
| transaction | SGEN | Common Stock | Sale | -$13.6K | -100 | -0.01% | $136.33 | 668K | Mar 7, 2022 | Direct | F1, F2 |
| transaction | SGEN | Common Stock | Options Exercise | $102K | +3.9K | +0.58% | $26.10 | 672K | Mar 7, 2022 | Direct | F1 |
| transaction | SGEN | Common Stock | Sale | -$518K | -3.9K | -0.58% | $132.72 | 668K | Mar 7, 2022 | Direct | F1, F2, F3 |
| transaction | SGEN | Common Stock | Options Exercise | $62.6K | +2.4K | +0.36% | $26.10 | 670K | Mar 7, 2022 | Direct | F1 |
| transaction | SGEN | Common Stock | Sale | -$321K | -2.4K | -0.36% | $133.69 | 668K | Mar 7, 2022 | Direct | F1, F2, F4 |
| transaction | SGEN | Common Stock | Options Exercise | $173K | +6.64K | +0.99% | $26.10 | 675K | Mar 7, 2022 | Direct | F1 |
| transaction | SGEN | Common Stock | Sale | -$895K | -6.64K | -0.98% | $134.74 | 668K | Mar 7, 2022 | Direct | F1, F2, F5 |
| transaction | SGEN | Common Stock | Options Exercise | $104K | +4K | +0.6% | $26.10 | 672K | Mar 7, 2022 | Direct | F1 |
| transaction | SGEN | Common Stock | Sale | -$542K | -4K | -0.6% | $135.62 | 668K | Mar 7, 2022 | Direct | F1, F2, F6 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | SGEN | Non-Qualified Stock Option (right to buy) | Options Exercise | $0 | -100 | -0.1% | $0.00 | 102K | Mar 7, 2022 | Common Stock | 100 | $26.10 | Direct | F7 |
| transaction | SGEN | Non-Qualified Stock Option (right to buy) | Options Exercise | $0 | -3.9K | -3.82% | $0.00 | 98.3K | Mar 7, 2022 | Common Stock | 3.9K | $26.10 | Direct | F7 |
| transaction | SGEN | Non-Qualified Stock Option (right to buy) | Options Exercise | $0 | -2.4K | -2.44% | $0.00 | 95.9K | Mar 7, 2022 | Common Stock | 2.4K | $26.10 | Direct | F7 |
| transaction | SGEN | Non-Qualified Stock Option (right to buy) | Options Exercise | $0 | -6.64K | -6.93% | $0.00 | 89.2K | Mar 7, 2022 | Common Stock | 6.64K | $26.10 | Direct | F7 |
| transaction | SGEN | Non-Qualified Stock Option (right to buy) | Options Exercise | $0 | -4K | -4.48% | $0.00 | 85.2K | Mar 7, 2022 | Common Stock | 4K | $26.10 | Direct | F7 |
| Id | Content |
|---|---|
| F1 | Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting. |
| F2 | The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. |
| F3 | Reflects sales of common stock executed in multiple transactions at prices ranging from $132.15 to $133.14. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. |
| F4 | Reflects sales of common stock executed in multiple transactions at prices ranging from $133.16 to $134.09. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. |
| F5 | Reflects sales of common stock executed in multiple transactions at prices ranging from $134.26 to $135.25. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. |
| F6 | Reflects sales of common stock executed in multiple transactions at prices ranging from $135.28 to $136.25. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. |
| F7 | Options vested at a rate of 25% on 8/20/13 and monthly thereafter until all the options were fully vested on 8/20/16. |